Bruker Adjusts FY25 Revenue Forecast, Launches Cost Management Plan to Achieve Double-Digit EPS Growth

Bruker has revised its FY25 revenue forecast to $3.43-$3.5 billion, down from $3.48-$3.55 billion. The company has launched a cost management plan to cut annual expenses by $100-$120 million by FY26, aiming for double-digit EPS growth despite demand challenges. Bruker remains hopeful for a partial recovery in demand by 2026.

Bruker Corporation (Nasdaq: BRKR) has revised its fiscal year 2025 (FY25) revenue forecast, reducing it to a range of $3.43 billion to $3.50 billion, down from the previously projected $3.48 billion to $3.55 billion. This adjustment reflects the company's response to challenging demand conditions in key markets, such as the U.S. academic market, biopharma, and industrial sectors, as well as the impact of tariffs and currency headwinds [1].

The company's second-quarter 2025 (Q2 2025) financial results showed revenues of $797.4 million, a decrease of 0.4% year-over-year (yoy), with organic revenue down 7.0% and constant-exchange rate (CER) revenue down 3.3% yoy. GAAP diluted earnings per share (EPS) remained at $0.05, while non-GAAP diluted EPS decreased to $0.32, down 38.5% compared to Q2 2024 [1].

To mitigate the impact of these challenges, Bruker has launched a significantly expanded cost management initiative aimed at reducing annual costs by $100 million to $120 million in FY2026. This initiative supports the company's commitment to resume rapid margin expansion and achieve double-digit EPS growth, even in a scenario where demand remains muted. Bruker remains optimistic for a partial demand recovery in FY2026, leveraging its successful track record of rebounding from previous market disruptions [1].

The company's updated FY25 revenue guidance reflects a year-over-year reported growth of 2% to 4%, with CER revenue approximately flat and an organic revenue decline of 2% to 4%. Non-GAAP EPS is now expected to be between $1.95 and $2.05, compared to $2.41 in FY2024 [1].

Bruker will host a conference call and webcast on August 4, 2025, at 8:30 am Eastern Daylight Time, to discuss its financial results, business outlook, and related corporate and financial matters. Investors can access the webcast at https://ir.bruker.com and dial in via telephone to participate [1].

References:

[1] Bruker Corporation. (2025, August 4). Bruker Reports Second Quarter 2025 Financial Results. Retrieved from https://ir.bruker.com/press-releases/press-release-details/2025/Bruker-Reports-Second-Quarter-2025-Financial-Results/default.aspx